CaraMed Capital logo

CaraMed Capital

Oceania, Auckland, New Zealand, Auckland

Description

CaraMed Capital is a deep-health tech venture capital fund.

Investor Profile

CaraMed Capital has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Country Focus

  • Australia (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CaraMed Capital frequently co-invest with?

UNSW Founders
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Negev Capital
North America, Midland, Cayman Islands, Grand Cayman
Co-Investments: 1
Lionheart Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Main Sequence Ventures
Oceania, New South Wales, Australia, Sydney
Co-Investments: 1
Empath Ventures
North America, California, United States, Los Angeles
Co-Investments: 1

What are some of recent deals done by CaraMed Capital?

Psylo

Sydney, New South Wales, Australia

Psylo is a drug development company that focuses on next-generation psychedelics.

Biotechnology
SeedOct 27, 2022
Amount Raised: $3,225,276